ONTOLOGY REPORT - ANNOTATIONS
Term: sertraline
Accession: CHEBI:9123
browse the term
Definition: A member of the class of tetralins that is tetralin which is substituted at positions 1 and 4 by a methylamino and a 3,4-dichlorophenyl group, respectively (the S,S diastereoisomer). A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as the hydrochloride salt as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder.
Synonyms: exact_synonym: (1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
related_synonym: (1S,4S)-sertraline; (1S-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine; C17H17Cl2N; CP 51974; InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1; InChIKey=VGKDLMBJGBXTGI-SJCJKPOMSA-N; [H][C@]1(CC[C@H](NC)c2ccccc12)c1ccc(Cl)c(Cl)c1; cis-(+)-sertraline; sertralina; sertralinum
xref_casrn: 79617-96-2
xref: ChEMBL:153616 "ChEMBL COMPOUND"; ChemIDplus:5753709 "Beilstein Registry Number"; ChemIDplus:79617-96-2 "CAS Registry Number"; CiteXplore:19502000 "PubMed citation"; CiteXplore:21823671 "PubMed citation"; DrugBank:DB01104 "DrugBank"; HMDB:HMDB05010 "HMDB"; KEGG COMPOUND:79617-96-2 "CAS Registry Number"; KEGG COMPOUND:C07246 "KEGG COMPOUND"; KEGG DRUG:D02360 "KEGG DRUG"
xref_mesh: MESH:D020280
xref: NIST Chemistry WebBook:79617-96-2 "CAS Registry Number"; Patent:US4536518 "Patent"; Reaxys:5753709 "Reaxys Registry Number"; Wikipedia:Sertraline "Wikipedia"
cyclic_relationship: is_conjugate_base_of CHEBI:64214
sertraline
G
Abcb1a
ATP-binding cassette, sub-family B (MDR/TAP), member 1A
increases activity
ISO
4
21,709,855
21,796,628
RGD:6480464
CTD
G
Akt1
v-akt murine thymoma viral oncogene homolog 1
multiple interactions
EXP
6
137,640,482
137,657,552
RGD:6480464
CTD
G
Asah1
N-acylsphingosine amidohydrolase (acid ceramidase) 1
increases expression
ISO
16
54,279,253
54,311,084
RGD:6480464
CTD
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
4
32,758,866
32,776,220
RGD:6480464
CTD
G
Asns
asparagine synthetase (glutamine-hydrolyzing)
increases expression
ISO
4
32,758,866
32,776,220
RGD:6480464
CTD
G
Bcl2
B-cell CLL/lymphoma 2
affects expression
ISO
13
12,730,736
12,905,108
RGD:6480464
CTD
G
Bdnf
brain-derived neurotrophic factor
increases expression
ISO
RGD:6480464
CTD
G
Cat
catalase
multiple interactions
EXP
3
88,654,077
88,686,212
RGD:6480464
CTD
G
Creb1
cAMP responsive element binding protein 1
increases expression
EXP
9
63,170,785
63,234,727
RGD:6480464
CTD
G
Cyp2b2
cytochrome P450, family 2, subfamily b, polypeptide 2
multiple interactions
ISO
1
81,345,425
81,359,415
RGD:6480464
CTD
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
ISO
1
243,281,320
243,320,945
RGD:6480464
CTD
G
Cyp2c11
cytochrome P450, subfamily 2, polypeptide 11
multiple interactions
ISO
1
243,281,320
243,320,945
RGD:6480464
CTD
G
Cyp2d3
cytochrome P450, family 2, subfamily d, polypeptide 3
multiple interactions
ISO
7
120,778,783
120,783,140
RGD:6480464
CTD
G
Cyp2d4
cytochrome P450, family 2, subfamily d, polypeptide 4
multiple interactions
ISO
7
120,742,273
120,752,274
RGD:6480464
CTD
G
Cyp3a2
cytochrome P450, family 3, subfamily a, polypeptide 2
multiple interactions
ISO
12
9,517,016
9,541,000
RGD:6480464
CTD
G
Dbh
dopamine beta-hydroxylase (dopamine beta-monooxygenase)
increases response to substance
ISO
3
6,052,706
6,069,826
RGD:6480464
CTD
G
Dnajc5
DnaJ (Hsp40) homolog, subfamily C, member 5
increases expression
ISO
3
170,655,557
170,685,855
RGD:6480464
CTD
G
Drd1
dopamine receptor D1
increases expression
EXP
17
16,655,926
16,658,161
RGD:6480464
CTD
G
Fabp1
fatty acid binding protein 1, liver
increases expression
ISO
4
104,412,200
104,415,981
RGD:6480464
CTD
G
Fabp1
fatty acid binding protein 1, liver
increases expression
ISO
4
104,412,200
104,415,981
RGD:6480464
CTD
G
Fos
FBJ osteosarcoma oncogene
decreases expression
EXP
6
109,559,135
109,562,001
RGD:6480464
CTD
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
1
185,941,893
185,984,348
RGD:6480464
CTD
G
Gdpd3
glycerophosphodiester phosphodiesterase domain containing 3
increases expression
ISO
1
185,941,893
185,984,348
RGD:6480464
CTD
G
Hpn
hepsin
increases expression
ISO
1
86,145,615
86,161,091
RGD:6480464
CTD
G
Hspa8
heat shock 70kDa protein 8
increases expression
EXP
8
43,784,035
43,787,760
RGD:6480464
CTD
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
multiple interactions
EXP
2
36,434,518
36,435,786
RGD:6480464
CTD
G
Htr1a
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
increases expression
EXP
2
36,434,518
36,435,786
RGD:6480464
CTD
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
multiple interactions
EXP
15
55,463,743
55,532,293
RGD:6480464
CTD
G
Htr2a
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled
increases expression
EXP
15
55,463,743
55,532,293
RGD:6480464
CTD
G
Htr2c
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
multiple interactions
EXP
X
31,012,921
31,244,127
RGD:6480464
CTD
G
Htr2c
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled
increases expression
EXP
X
31,012,921
31,244,127
RGD:6480464
CTD
G
Inhbe
inhibin beta E
increases expression
ISO
7
67,308,713
67,310,138
RGD:6480464
CTD
G
Inhbe
inhibin beta E
increases expression
ISO
7
67,308,713
67,310,138
RGD:6480464
CTD
G
Ins2
insulin 2
multiple interactions
EXP
1
202,935,548
202,936,379
RGD:6480464
CTD
G
Irs1
insulin receptor substrate 1
multiple interactions
EXP
9
81,585,251
81,638,071
RGD:6480464
CTD
G
Irs1
insulin receptor substrate 1
decreases activity
EXP
9
81,585,251
81,638,071
RGD:6480464
CTD
G
Kcnj3
potassium inwardly-rectifying channel, subfamily J, member 3
multiple interactions
ISO
3
37,068,672
37,256,990
RGD:6480464
CTD
G
Kcnj5
potassium inwardly-rectifying channel, subfamily J, member 5
multiple interactions
ISO
8
32,082,866
32,104,412
RGD:6480464
CTD
G
Kcnj6
potassium inwardly-rectifying channel, subfamily J, member 6
multiple interactions
ISO
11
35,025,118
35,116,500
RGD:6480464
CTD
G
LOC500300
similar to hypothetical protein MGC6835
increases expression
ISO
4
153,000,782
153,002,562
RGD:6480464
CTD
G
LOC500300
similar to hypothetical protein MGC6835
increases expression
ISO
4
153,000,782
153,002,562
RGD:6480464
CTD
G
Lss
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
increases expression
ISO
20
12,507,575
12,534,612
RGD:6480464
CTD
G
Lss
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)
increases expression
ISO
20
12,507,575
12,534,612
RGD:6480464
CTD
G
Maoa
monoamine oxidase A
multiple interactions
ISO
X
17,678,960
17,745,908
RGD:6480464
CTD
G
Maob
monoamine oxidase B
multiple interactions
ISO
X
17,553,529
17,657,852
RGD:6480464
CTD
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
EXP
11
85,968,732
86,030,387
RGD:6480464
CTD
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
EXP
1
185,935,044
185,941,245
RGD:6480464
CTD
G
Mapk8
mitogen-activated protein kinase 8
multiple interactions
EXP
16
8,925,133
9,004,897
RGD:6480464
CTD
G
Nr0b2
nuclear receptor subfamily 0, group B, member 2
increases expression
ISO
5
151,524,685
151,528,000
RGD:6480464
CTD
G
Nupr1
nuclear protein, transcriptional regulator, 1
increases expression
ISO
1
185,770,310
185,772,313
RGD:6480464
CTD
G
Nupr1
nuclear protein, transcriptional regulator, 1
increases expression
ISO
1
185,770,310
185,772,313
RGD:6480464
CTD
G
Pecam1
platelet/endothelial cell adhesion molecule 1
decreases expression
ISO
10
96,056,220
96,057,232
RGD:6480464
CTD
G
Pf4
platelet factor 4
decreases expression
ISO
14
18,812,550
18,813,259
RGD:6480464
CTD
G
Phyh
phytanoyl-CoA 2-hydroxylase
increases expression
ISO
17
84,418,173
84,435,073
RGD:6480464
CTD
G
Ppbp
pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)
decreases expression
ISO
14
18,816,434
18,817,238
RGD:6480464
CTD
G
Ptgs2
prostaglandin-endoperoxide synthase 2
decreases expression
ISO
13
64,427,288
64,432,978
RGD:6480464
CTD
G
Rnf103
ring finger protein 103
increases expression
EXP
4
104,762,184
104,778,157
RGD:6480464
CTD
G
Rps6kb1
ribosomal protein S6 kinase, polypeptide 1
multiple interactions
EXP
10
76,657,024
76,698,088
RGD:6480464
CTD
G
Sele
selectin E
decreases expression
ISO
13
79,813,455
79,822,845
RGD:6480464
CTD
G
Sele
selectin E
decreases expression
ISO
13
79,813,455
79,822,845
RGD:6480464
CTD
G
Selp
selectin P
decreases expression
ISO
13
79,886,614
79,922,180
RGD:6480464
CTD
G
Selp
selectin P
decreases expression
ISO
13
79,886,614
79,922,180
RGD:6480464
CTD
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
6
128,461,775
128,469,309
RGD:6480464
CTD
G
Serpina3n
serine (or cysteine) peptidase inhibitor, clade A, member 3N
increases expression
ISO
6
128,461,775
128,469,309
RGD:6480464
CTD
G
Serpini1
serpin peptidase inhibitor, clade I (neuroserpin), member 1
increases expression
EXP
2
166,445,765
166,555,032
RGD:6480464
CTD
G
Slc2a3
solute carrier family 2 (facilitated glucose transporter), member 3
decreases expression
ISO
4
159,210,116
159,221,169
RGD:6480464
CTD
G
Slc2a3
solute carrier family 2 (facilitated glucose transporter), member 3
decreases expression
ISO
4
159,210,116
159,221,169
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
multiple interactions
ISO
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
increases response to substance
ISO
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
multiple interactions
EXP
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
decreases expression
ISO
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
affects response to substance
ISO
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
multiple interactions
EXP
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
decreases expression
EXP
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Slc6a4
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4
increases expression
EXP
10
67,134,790
67,155,891
RGD:6480464
CTD
G
Stat3
signal transducer and activator of transcription 3 (acute-phase response factor)
decreases expression
ISO
10
89,821,078
89,872,970
RGD:6480464
CTD
G
Tagln
transgelin
decreases expression
ISO
8
48,902,208
48,907,682
RGD:6480464
CTD
G
Tnf
tumor necrosis factor
decreases secretion
ISO
20
3,661,000
3,663,618
RGD:6480464
CTD
G
Tph2
tryptophan hydroxylase 2
multiple interactions
EXP
7
54,321,033
54,430,706
RGD:6480464
CTD
G
Tph2
tryptophan hydroxylase 2
increases activity
EXP
7
54,321,033
54,430,706
RGD:6480464
CTD
G
Tph2
tryptophan hydroxylase 2
increases expression
EXP
7
54,321,033
54,430,706
RGD:6480464
CTD
G
Ugt2b7
UDP glucuronosyltransferase 2 family, polypeptide B7
multiple interactions
ISO
14
22,499,152
22,522,842
RGD:6480464
CTD
G
Vcam1
vascular cell adhesion molecule 1
increases expression
ISO
2
212,277,654
212,297,376
RGD:6480464
CTD
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
10
98,722,266
98,753,713
RGD:6480464
CTD
G
Wipi1
WD repeat domain, phosphoinositide interacting 1
increases expression
ISO
10
98,722,266
98,753,713
RGD:6480464
CTD
Term paths to the root one longest all shortest one shortest all one shortest and longest all longest